DXR Daxor Corporation
Healthcare$10.55-2.45%ClosedMarket Cap: $53.2M
As of 2026-05-26
Valuation
P/E (TTM)
4.91
PEG
0.06
P/B
1.19
P/S
362.98
EV/EBITDA
5.72
DCF Value
$-0.03
FCF Yield
0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-57.5%
Operating Margin
6174.2%
Net Margin
6105.3%
ROE
22.5%
ROA
19.9%
ROIC
20.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $131.8K | -79.4% | $9.5M | $9.5M | $— | — |
| FY null | $503.4K | 37.5% | $9.2M | $9.2M | $— | — |
| Q2 null | $18.3K | 100.0% | $-269.5K | $-369.7K | $— | — |
| Q4 null | $695.3K | 89.3% | $2.2M | $2.2M | $— | — |
| FY null | $2.1M | 100.0% | $621.4K | $536.3K | $— | — |
| Q2 null | $71.8K | 100.0% | $-297.6K | $-1.6M | $— | — |
| Q4 null | $82.4K | 100.0% | $3.1M | $3.3M | $— | — |
| FY null | $34.6M | 99.5% | $329.7K | $280.6K | $— | — |
| Q2 null | $81.0K | 100.0% | $-366.5K | $-3.0M | $— | — |
| Q4 null | $96.4K | 100.0% | $-624.2K | $7.0M | $— | — |
| FY null | $-353.4K | 407.6% | $5.3M | $5.2M | $— | — |
| Q2 null | $135.2K | 100.0% | $-235.5K | $-1.8M | $— | — |